Results 231 to 240 of about 22,248,138 (428)

DMAP-Catalyzed One-Pot Synthesis of Quinazoline-2,4-diones from 2‑Aminobenzamides and Di-tert-butyl Dicarbonate

ACS Omega, 2020
Hui Chen, Peng Li, Rongfei Qin, Hong Yan, Gang Li, Haihong Huang   +5 more
doaj   +1 more source

Substance P release from rat dura mater is inversely correlated with CGRP release- experiments using glycerol trinitrate and anti-CGRP antibodies. [PDF]

J Headache Pain
Dux M, Messlinger K.
europepmc   +1 more source

Ultrastructural identification of substance P cells and their processes in rat sensory ganglia and their terminals in the spinal cord by immunocytochemistry

, 1977
Victoria Chan‐Palay, Sanford L. Palay
openalex   +1 more source

Specific labeling of rat brain substance P receptor with [3H]physalaemin [PDF]

, 1985
P Mohini, SW Bahouth, D. E. BRUNDISH, J M Musacchio   +3 more
openalex   +1 more source

An antinociceptive role for substance P in acid-induced chronic muscle pain

Proceedings of the National Academy of Sciences of the United States of America, 2011
Chia-Ching John Lin, Wei-Nan Chen, Chien-Ju Chen, Yi-Wen Lin, A. Zimmer, Chih-Cheng Chen   +5 more
semanticscholar   +1 more source

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source

Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP success. [PDF]

J Headache Pain
Pellesi L, Edvinsson L.
europepmc   +1 more source

Substance P and Renshaw cells: a new concept of inhibitory synaptic interactions.

, 1977
G Belcher, R. W. Ryall
openalex   +2 more sources

White mineral and substance P [PDF]

Cardiovascular Research, 1996
openaire   +3 more sources

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source